Cargando…
Serological response to vaccination against coronavirus disease-19 in patients with inflammatory bowel disease
Vaccination against coronavirus disease-19 (COVID-19) is effective in preventing the occurrence or reduction in the severity of the infection. Patients with inflammatory bowel disease (IBD) are on immunomodulators, which may alter serological response to vaccination against COVID-19. Accordingly, we...
Autores principales: | Mathur, Akash, Sahu, Shikha, Rai, Sushmita, Ghoshal, Ujjala, Ghoshal, Uday C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811048/ https://www.ncbi.nlm.nih.gov/pubmed/36598745 http://dx.doi.org/10.1007/s12664-022-01323-7 |
Ejemplares similares
-
Care of inflammatory bowel disease patients during coronavirus disease‐19 pandemic using digital health‐care technology
por: Ghoshal, Uday C, et al.
Publicado: (2021) -
The Spectrum of Gastrointestinal Symptoms in Patients With Coronavirus Disease-19: Predictors, Relationship With Disease Severity, and Outcome
por: Ghoshal, Uday C., et al.
Publicado: (2020) -
Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis
por: Shukla, Ratnakar, et al.
Publicado: (2018) -
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
por: Ghoshal, Uday C., et al.
Publicado: (2017) -
Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review
por: Ghoshal, Uday C., et al.
Publicado: (2020)